The U.S. Supreme Court on Friday handed down a decision on the availability of mifepristone, an ingredient commonly employed in the treatment of abortions. The case was brought before the Supreme Court after the federal judge had ruled earlier in the month Food and Drug Administration improperly granted the drug approval 23 years prior to that. (Jacquelyn Martin/AP)

The U.S. Supreme Court on Friday stayed lower court rulings prohibiting or restricting the FDA-approved usage of the abortion pill mifepristone into the near future.

However, the justices have for the moment, have put the matter to the 5th U.S. Circuit Court of Appeals, who has scheduled oral arguments to be held on May 17. If depending on the 5th Circuit rules, the case is likely to return to the Supreme Court, with the possibility of a ruling in the coming term.

The decision of the court will mean that for now at least, the medication is widely accessible, at least in states that allow abortion for as long as 10 weeks into an unborn baby.

Dissidents Justices who dissent were Justices Clarence Thomas and Samuel Alito.

In his Dissent, Alito argued, “As narrowed by the Court of Appeals, the stay that would be in effect should we fail to expand the scope of the stay would not eliminate Mifepristone from the market. It would only bring back the conditions that were in place (and the Government was able to defend) from 2000 until the year 2016 under three administrations of Presidents.”

President Biden announced on Friday his administration will continue to stand up for the FDA’s endorsement for the drug mifepristone. He also demanded Americans to elect legislators to adopt a law that restores the rights of abortion.

“I will continue to support the FDA’s evidence-based approval for mifepristone. My Administration continues to fight for FDA’s authority as an independent expert to review, approve and regulate a variety of prescription drugs” Biden said in a statement.

“The risks could not be greater for women across America. Ich will keep fighting political assaults on the health of women. However, let’s be crystal clear: the American people need to continue to utilize their vote to voice their opinion, and select the Congress that is willing to pass legislation that will restore the protections provided by Roe Wade. Wade,” Biden declared.

The most recent legal battle concerning abortion started on with the day of 7 April Texas in Texas. U.S. District Judge Matthew Kacsmaryk an pro-abortion agitator, issued an all-over ban on mifepristone and declared that the FDA did not have the right to approve the drug more than 23 years back. Within a few minutes of the decision, U.S. District Judge Thomas O. Rice of Washington State issued a different decision. In a lawsuit that was brought by 17 states and Washington state and the District of Columbia seeking to extend Mifepristone’s use Rice stated it was necessary to keep the existing FDA rules should be maintained.

In April, the matter got more complicated after five judges from the U.S. Circuit Court of Appeals partially changed its mind on the Texas ruling of Kacsmaryk. Since the time limit to challenge FDA acceptance of a drug has been passed the appeals court decided that mifepristone was able to be used for up to seven weeks after the birth in states that allow abortionseven though it is known that FDA has endorsed the that the pill be used for as long as 10 weeks into the pregnancy.

Additionally the appeals court wanted to rescind rules in place in 2015 which have helped facilitate accessibility to pills for abortionfor instance, rules that permit patients wanting to have an abortion access the pills via mail, and rules that allow telemedicine appointments with doctors. In contrast, the appeals court tried to enforce rules that have not been in place since the year 2016, for instance, the requirement for three appointments in person for those taking the medication and prohibition on the lower-cost versions of the medication.

There is a slim chance for the appellate court to significantly alter its position after hearing an oral argument in this case. The 42-page preliminary ruling is based, at least in part in part, on the Comstock Act, which for a long time has been ignored or not applied. The law was passed in 1873. law sought to stop the distribution of sexually explicit or sexually pornographic materials and also to prohibit the mailing to any drug, product or medication used to prevent birth or to facilitate “unlawful abortion.”

No matter how the appeals court makes its decision however it is almost certain that there will be a challenge from the Biden administration on behalf of FDA as well as Danco Laboratories, maker of the top brand of mifepristone called Mifeprex. In their briefs filed so far in the past, they have noted that pills for medical abortions are the main cause of abortions occurring in the U.S. today. They also provide a myriad of tests and studies proving that the medication is extremely safe to use for as long as 10 weeks into the pregnancy.

The FDA and Danco argue that, were their decision by the Fifth Circuit made legal, it could result in “regulatory chaos throughout the nation.” According to Danco said in their brief outcome is “an unsustainable limbo” not just for Danco that is unable to legally distribute and market its drug, but also for the FDA doctors, the FDA health systems, and women, many of whom take the drug to prevent miscarriage.

Copyright 2023 NPR. For more information, visit https://www.npr.org.